See the DrugPatentWatch profile for linzess
The cost of Linzess (linaclotide) varies significantly depending on insurance coverage, pharmacy, and dosage. Without insurance, a 30-day supply of Linzess can range from approximately $450 to over $600 [1]. For example, a 290 mcg daily dosage might cost around $474.39 at some pharmacies [1].
What influences the price of Linzess?
The price of Linzess is influenced by several factors, including the specific dosage prescribed (e.g., 145 mcg, 290 mcg), the quantity dispensed, and the retail pharmacy where it is purchased [1]. Insurance plans also play a substantial role; copay cards and patient assistance programs may be available to reduce out-of-pocket expenses for eligible individuals [2].
How can I get a discount on Linzess?
Patients may be able to reduce the cost of Linzess through various discount programs. The manufacturer offers a savings card that can lower the monthly copay for eligible commercially insured patients to as little as $30 [3]. For those without insurance or with high deductibles, free drug programs or discount cards from third-party websites might offer savings, though these vary [1][2].
How long does Linzess patent protection last?
Information regarding the specific patent expiration dates for Linzess is available through specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on when market exclusivity might end [4]. This is crucial for understanding when generic versions might become available.
Who makes Linzess?
Linzess is a medication developed and marketed by Ironwood Pharmaceuticals and Allergan [5].
What are the alternatives to Linzess?
There are several other medications available for treating chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), which may be considered alternatives to Linzess. These include linaclotide alternatives like plecanatide (Trulance), lubiprostone (Amitiza), and certain osmotic laxatives like polyethylene glycol [6]. The choice of alternative often depends on the specific condition being treated and individual patient response.